Cart
sales@molnova.com
Dehydroabietic acid
CAS No. 1740-19-8
Dehydroabietic acid ( —— )
Catalog No. M18122 CAS No. 1740-19-8
Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 248 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 500MG | 845 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydroabietic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
-
DescriptionDehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEBV
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1740-19-8
-
Formula Weight300.44
-
Molecular FormulaC20H28O2
-
Purity98%
-
Solubility——
-
SMILESCC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Olmutinib
Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.?
-
Panitumumab
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).
-
Monastrol（b）
Monastrol is a potent and cell-permeable inhibitor of the mitotic kinesin Eg5.
